Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Peer Tfelt-Hansen. (2021) Pharmacological strategies to treat attacks of episodic migraine in adults. Expert Opinion on Pharmacotherapy 22:3, pages 305-316.
Read now
Read now
Wade Cooper, Erin Gautier Doty, Helen Hochstetler, Ann Hake & Vincent Martin. (2020) The current state of acute treatment for migraine in adults in the United States. Postgraduate Medicine 132:7, pages 581-589.
Read now
Read now
Martina Curto, Fabiola Cipolla, Giusy Ylenia Cisale, Matilde Capi, Valerio Spuntarelli, Martina Guglielmetti, Paolo Martelletti & Luana Lionetto. (2020) Profiling lasmiditan as a treatment option for migraine. Expert Opinion on Pharmacotherapy 21:2, pages 147-153.
Read now
Read now
Julio Pascual & Carlos Vila. (2019) Almotriptan: a review of 20 years’ clinical experience. Expert Review of Neurotherapeutics 19:8, pages 759-768.
Read now
Read now
Articles from other publishers (24)
G. R. Tabeeva, A. V. Amelin, L. R. Akhmadeeva, A. B. Danilov, O. B. Doronina, M. I. Koreshkina, N. V. Latysheva, E. G. Mendelevich, I. V. Sarvilina, A. V. Sergeev, K. V. Skorobogatykh & E. G. Filatova. (2023) Optimization of migraine attacks relief. Neurology, Neuropsychiatry, Psychosomatics 15:2, pages 126-133.
Crossref
Crossref
Waqar Siddique, Muhammad Zaman, Rai Muhammad Sarfraz, Muhammad Hammad Butt, Atta Ur Rehman, Noman Fassih, Ghadeer M. Albadrani, Roula Bayram, Mohammad Y. Alfaifi & Mohamed M. Abdel-Daim. (2022) The Development of Eletriptan Hydrobromide Immediate Release Buccal Films Using Central Composite Rotatable Design: An In Vivo and In Vitro Approach. Polymers 14:19, pages 3981.
Crossref
Crossref
Roger Gregory Biringer. (2022) Migraine signaling pathways: amino acid metabolites that regulate migraine and predispose migraineurs to headache. Molecular and Cellular Biochemistry 477:9, pages 2269-2296.
Crossref
Crossref
Farzin Zobdeh, Aziza Kraiem, Misty M. Attwood, Vladimir N. Chubarev, Vadim V. Tarasov, Helgi B. Schiöth & Jessica Mwinyi. (2021) Pharmacological treatment of migraine: Drug classes, mechanisms of action, clinical trials and new treatments. British Journal of Pharmacology 178:23, pages 4588-4607.
Crossref
Crossref
Juliana K Beauchene & Terri L Levien. (2021) Lasmiditan: Acute Migraine Treatment Without Vasoconstriction. A Review. Journal of Pharmacy Technology 37:5, pages 244-253.
Crossref
Crossref
Paul A DeJulio, Joshua K Perese, Nathaniel M Schuster & Jessica C Oswald. (2021) Lasmiditan for the acute treatment of migraine. Pain Management 11:5, pages 437-449.
Crossref
Crossref
Epiphani C. Simmons, Natalie E. Scholpa & Rick G. Schnellmann. (2021) FDA-approved 5-HT1F receptor agonist lasmiditan induces mitochondrial biogenesis and enhances locomotor and blood-spinal cord barrier recovery after spinal cord injury. Experimental Neurology 341, pages 113720.
Crossref
Crossref
Matilde Capi, Valerio De Angelis, Donatella De Bernardini, Ottavia De Luca, Fabiola Cipolla, Luana Lionetto, Maurizio Simmaco & Paolo Martelletti. (2021) CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine. Journal of Clinical Medicine 10:7, pages 1429.
Crossref
Crossref
Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding & Sepideh Afshar. (2021) Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases. International Journal of Molecular Sciences 22:6, pages 2805.
Crossref
Crossref
Arpita Maitra, Sabyasachi Mukhopadhyay, Abhijit Das & Shouvik Choudhury. (2021) Newer Horizon for Treatment of Acute Attack of Migraine: Lasmiditan and Ubrogepant. Neurology India 69:6, pages 1759.
Crossref
Crossref
Alok Singh, Dhyuti Gupta & Abhishek Singh. (2021) Ditans vs Gepants: A Systematic Review and Indirect Network Meta-Analysis for Comparative Analysis of Efficacy and Safety. Neurology India 69:7, pages 43.
Crossref
Crossref
Theodoros Mavridis, Marianthi Breza, Christina I. Deligianni & Dimos D. Mitsikostas. 2020. Migraine. Migraine.
G. Mick. (2020) Une nouvelle génération de traitements spécifiques de la crise migraineuse : ditans et gépants. Douleur et Analgésie 33:3, pages 153-156.
Crossref
Crossref
Alberto Raggi & Raffaele Ferri. (2020) Information Processing in Migraine: A Review of Studies on P300. Applied Psychophysiology and Biofeedback 45:3, pages 131-144.
Crossref
Crossref
JamirPitton Rissardo & AnaLetícia Fornari Caprara. (2020) The ditans, a new class for acute migraine: Minireview. Journal of Current Research in Scientific Medicine 6:1, pages 11.
Crossref
Crossref
Leda Marina Pomes, Martina Guglielmetti, Enrico Bertamino, Maurizio Simmaco, Marina Borro & Paolo Martelletti. (2019) Optimising migraine treatment: from drug-drug interactions to personalized medicine. The Journal of Headache and Pain 20:1.
Crossref
Crossref
Thien Phu Do, Song Guo & Messoud Ashina. (2019) Therapeutic novelties in migraine: new drugs, new hope?. The Journal of Headache and Pain 20:1.
Crossref
Crossref
Tess V. Dupre, Dorea P. Jenkins, Robin C. Muise-Helmericks & Rick G. Schnellmann. (2019) The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cells. Biochemical Pharmacology 169, pages 113644.
Crossref
Crossref
Jan Lewis Brandes, Suzanne Klise, John H Krege, Michael Case, Rashna Khanna, Raghavendra Vasudeva, Joel Raskin, Eric M Pearlman & David Kudrow. (2019) Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study). Cephalalgia 39:11, pages 1343-1357.
Crossref
Crossref
Erin Gautier Doty, John H Krege, Leah Jin, Joel Raskin, Rashmi B Halker Singh & Kavita Kalidas. (2019) Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine. Cephalalgia 39:12, pages 1569-1576.
Crossref
Crossref
Claire E. J. Ceriani, Danielle A. Wilhour & Stephen D. Silberstein. (2019) Novel Medications for the Treatment of Migraine. Headache: The Journal of Head and Face Pain 59:9, pages 1597-1608.
Crossref
Crossref
A. Ducros. (2019) Actualités thérapeutiques dans la migraine. Pratique Neurologique - FMC 10:3, pages 193-197.
Crossref
Crossref
Scot Walker. (2019) New Medications in the Treatment of Acute Migraine. Hospital Pharmacy 54:4, pages 229-231.
Crossref
Crossref
Katharina Kamm, Andreas Straube & Lars Neeb. (2019) Migräne — Therapie im WandelMigraine — therapy in transition. MMW - Fortschritte der Medizin 161:12, pages 50-58.
Crossref
Crossref